GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » Net Interest Margin (Bank Only) %

SK Bioscience Co (XKRX:302440) Net Interest Margin (Bank Only) %

View and export this data going back to 2021. Start your Free Trial

What is SK Bioscience Co Net Interest Margin (Bank Only) %?

Net Interest Margin (Bank Only) % only applies to banks.

SK Bioscience Co (XKRX:302440) Business Description

Traded in Other Exchanges
310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494
SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.